{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T03:39:10Z","timestamp":1784259550754,"version":"3.55.0"},"reference-count":26,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,8,31]],"date-time":"2022-08-31T00:00:00Z","timestamp":1661904000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Sarcoidosis is a systemic inflammatory disease that is characterized by non-caseating granulomas. Besides the lung as classical site of involvement, extrapulmonary manifestations are common, for example cervical lymph nodes or the salivary glands. The aim of this investigation is the analysis of the long-term course of glandular symptoms with a focus on persisting sicca symptoms.<\/jats:p><\/jats:sec><jats:sec><jats:title>Materials and methods<\/jats:title><jats:p>All patients with the diagnosis of sarcoidosis over a period of 20 years in the departments of otorhinolaryngology, nephrology and pneumology were identified. In addition to clinical examinations and functional evaluation of the salivary glands, a sonographic examination of the salivary glands was carried out.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 76 patients were included in the study (age 35.1 \u00b1 21.6 years). At baseline, 32 out of 76 patients were suffering from xerostomia, 36 from dry eyes. While other salivary gland symptoms, such as gland enlargement, pain or facial nerve impairment, dissolved during the further course of the disease, xerostomia was still present in 29 and dry eyes in 35 out of 76 patients at the time of follow-up (which took place on average after 88.2 months).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Sicca symptoms persist in patients with the diagnosis of sarcoidosis, while other salivary gland symptoms completely dissolve during the further course of the disease. This development appears to be independent of the type of therapy and should be considered during the follow-up of these patients, since sicca symptoms can cause further ocular, oral and dental damage.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2022.975122","type":"journal-article","created":{"date-parts":[[2022,8,31]],"date-time":"2022-08-31T05:48:59Z","timestamp":1661924939000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Persisting sicca complaints in sarcoidosis"],"prefix":"10.3389","volume":"9","author":[{"given":"Benedikt","family":"Hofauer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Wiesner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaojun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konrad","family":"Stock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Friedhelm","family":"Peltz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Thuermel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Strassen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Knopf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,8,31]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1164\/ajrccm.164.10.2104046","article-title":"Clinical characteristics of patients in a case control study of sarcoidosis","volume":"164","author":"Baughman","year":"2001","journal-title":"Am J Respir Crit Care Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1097\/MCP.0000000000000715","article-title":"Sarcoidosis epidemiology: recent estimates of incidence, prevalence and risk factors","volume":"26","author":"Arkema","year":"2020","journal-title":"Curr Opin Pulm Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1093\/rheumatology\/ker213","article-title":"Rheumatic disorders affecting the head and neck: underestimated diseases","volume":"50","author":"Knopf","year":"2011","journal-title":"Rheumatology."},{"key":"B4","first-page":"1052","article-title":"Geoepidemiological big data approach to sarcoidosis: geographical and ethnic determinants","volume":"37","author":"Brito-Zer\u00f3n","year":"2019","journal-title":"Clin Exp Rheumatol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"3300","DOI":"10.1001\/jama.289.24.3300","article-title":"Sarcoidosis","volume":"289","author":"Thomas","year":"2003","journal-title":"JAMA."},{"key":"B6","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.chest.2018.02.003","article-title":"Clinical features of extrapulmonary sarcoidosis without lung involvement","volume":"154","author":"James","year":"2018","journal-title":"Chest."},{"key":"B7","first-page":"119","article-title":"The organ-specific extrapulmonary presentation of sarcoidosis: a frequent occurrence but a challenge to an early diagnosis. A 3-year-long prospective observational study","volume":"21","author":"Rizzato","year":"2004","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis."},{"key":"B8","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1159\/000083392","article-title":"Unusual presentation of sarcoidosis","volume":"72","author":"Rizzato","year":"2005","journal-title":"Respiration."},{"key":"B9","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s00106-016-0158-2","article-title":"Swelling of the submandibular and parotid glands: a description of possible differential diagnoses","volume":"64","author":"Hofauer","year":"2016","journal-title":"HNO."},{"key":"B10","first-page":"27","article-title":"Parotid gland sarcoidosis","volume":"17","author":"James","year":"2000","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis."},{"key":"B11","doi-asserted-by":"publisher","first-page":"2130","DOI":"10.1016\/j.ultrasmedbio.2016.04.011","article-title":"Sonoelastographic modalities in the evaluation of salivary gland characteristics in Sjogren's Syndrome","volume":"42","author":"Hofauer","year":"2016","journal-title":"Ultrasound Med Biol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1007\/s00106-017-0380-6","article-title":"Manifestations of autoimmune disorders in otorhinolaryngology: Classical symptoms and diagnostic approach","volume":"65","author":"Hofauer","year":"2017","journal-title":"HNO."},{"key":"B13","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1002\/hed.23022","article-title":"Head and neck sarcoidosis, from wait and see to tumor necrosis factor alpha therapy: a pilot study","volume":"35","author":"Knopf","year":"2013","journal-title":"Head Neck."},{"key":"B14","doi-asserted-by":"publisher","first-page":"e018865","DOI":"10.1136\/bmjopen-2017-018865","article-title":"Pulmonary sarcoidosis with and without extrapulmonary involvement: a cross-sectional and observational study in China","volume":"8","author":"Li","year":"2018","journal-title":"BMJ Open."},{"key":"B15","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1136\/ard.61.6.554","article-title":"Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group","volume":"61","author":"Vitali","year":"2002","journal-title":"Ann Rheum Dis."},{"key":"B16","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1378\/chest.123.2.406","article-title":"The diagnostic pathway to sarcoidosis","volume":"123","author":"Judson","year":"2003","journal-title":"Chest."},{"key":"B17","first-page":"2","article-title":"Scadding revisited: a proposed staging system for cardiac sarcoidosis","volume":"31","author":"Berman","year":"2014","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis."},{"key":"B18","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1093\/rheumatology\/35.10.972","article-title":"Parotid gland ultrasonography as a diagnostic tool in primary Sjogren's syndrome","volume":"35","author":"Makula","year":"1996","journal-title":"Br J Rheumatol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1111\/jop.12057","article-title":"Sarcoidosis and Sjogren's syndrome: clinical and salivary evaluation","volume":"42","author":"Mansour","year":"2013","journal-title":"J Oral Pathol Med."},{"key":"B20","doi-asserted-by":"publisher","first-page":"103","DOI":"10.3109\/03009748609102073","article-title":"Patients with primary Sjogren's syndrome treated for two months with evening primrose oil","volume":"15","author":"Oxholm","year":"1986","journal-title":"Scand J Rheumatol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"e3821","DOI":"10.1136\/bmj.e3821","article-title":"Primary Sjogren syndrome","volume":"344","author":"Ramos-Casals","year":"2012","journal-title":"BMJ."},{"key":"B22","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.oooo.2011.11.014","article-title":"Xerostomia and salivary hypofunction in vulnerable elders: prevalence and etiology","volume":"114","author":"Liu","year":"2012","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"2714","DOI":"10.1093\/rheumatology\/keaa687","article-title":"Baseline disease activity influences subsequent achievement of patient acceptable symptom state in Sjogren's syndrome","volume":"60","author":"Park","year":"2021","journal-title":"Rheumatology."},{"key":"B24","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1136\/annrheumdis-2014-206008","article-title":"Defining disease activity states and clinically meaningful improvement in primary Sjogren's syndrome with EULAR primary Sjogren's syndrome disease activity (ESSDAI) and patient-reported indexes (ESSPRI)","volume":"75","author":"Seror","year":"2016","journal-title":"Ann Rheum Dis."},{"key":"B25","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1136\/annrheumdis-2019-216114","article-title":"EULAR recommendations for the management of Sjogren's syndrome with topical and systemic therapies","volume":"79","author":"Ramos-Casals","year":"2020","journal-title":"Ann Rheum Dis."},{"key":"B26","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.3390\/jcm11092292","article-title":"Multimodal evaluation of long-term salivary gland alterations in sarcoidosis","volume":"11","author":"Hofauer","year":"2022","journal-title":"J Clin Med."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.975122\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,31]],"date-time":"2022-08-31T05:49:04Z","timestamp":1661924944000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.975122\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,31]]},"references-count":26,"alternative-id":["10.3389\/fmed.2022.975122"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2022.975122","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,31]]},"article-number":"975122"}}